Attached files

file filename
10-K - FORM 10-K - Jazz Pharmaceuticals plcd10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Jazz Pharmaceuticals plcdex211.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcdex311.htm
EX-10.55 - 2010 AND 2011 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS - Jazz Pharmaceuticals plcdex1055.htm
EX-10.54 - JAZZ PHARMACEUTICALS, INC. CASH BONUS PLAN - Jazz Pharmaceuticals plcdex1054.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcdex312.htm
EX-10.53 - SEPARATION AGREEMENT - ROBERT MYERS - Jazz Pharmaceuticals plcdex1053.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcdex321.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-143553, 333-150008, 333-158242, 333-165354 and 333-168799) pertaining to the 2003 Equity Incentive Plan, 2007 Equity Incentive Plan, 2007 Employee Stock Purchase Plan, 2007 Non-Employee Directors Stock Option Plan and Amended and Restated Directors Deferred Compensation Plan and the Registration Statements (Post-Effective Amendment No. 1 to Form S-1 on Form S-3 No. 333-163999, Post-Effective Amendment No. 1 to Form S-1 on Form S-3 No. 333-161350, Post-Effective Amendment No. 1 to Form S-1 on Form S-3 No. 333-161333 and Post-Effective Amendment No. 1 to Form S-3 No. 333-151593 ) of Jazz Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 8, 2011, with respect to the consolidated financial statements and schedule of Jazz Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Jazz Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

 

/s/    ERNST & YOUNG LLP

Palo Alto, California

March 8, 2011